Antimicrobial properties of diethylamine NONOate, a nitric oxide donor, against Escherichia coli: a pilot study

The emergence of SARS-CoV-2, the causative agent of COVID-19, highlights the increasing need for new and effective antiviral and antimicrobial agents. The FDA has recently banned several active ingredients used in hand sanitizers, including triclosan and benzethonium chloride. Nitric oxide (NO) is i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of antibiotics 2021-04, Vol.74 (4), p.260-265
Hauptverfasser: Sysel, Annette M., Dunphy, Michael J., Bauer, Joseph A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 265
container_issue 4
container_start_page 260
container_title Journal of antibiotics
container_volume 74
creator Sysel, Annette M.
Dunphy, Michael J.
Bauer, Joseph A.
description The emergence of SARS-CoV-2, the causative agent of COVID-19, highlights the increasing need for new and effective antiviral and antimicrobial agents. The FDA has recently banned several active ingredients used in hand sanitizers, including triclosan and benzethonium chloride. Nitric oxide (NO) is involved in the innate immune response and is a major component of macrophage-mediated attack on foreign viruses and bacteria. The specific aim of this study was to assess the antibacterial effects of 2-( N , N -diethylamino)-diazenolate-2-oxide (DEA-NONOate) against Escherichia coli ( E. coli ). A bacterial growth assay was compared to an adenosine triphosphate (ATP) activity assay at various time points to assess effects of DEA-NONOate on E. coli growth. A UV/Vis spectrophotometer was used to determine concentration of E. coli by measuring optical density (OD) at 630 nm. A luminescent assay was used to measure ATP activity correlating to viable cells. DEA-NONOate at a concentration of 65 mM was able to inhibit the growth of E. coli with the same efficacy as 1 μg ml −1 concentration of ciprofloxacin. Both the OD and ATP assays demonstrated a 99.9% reduction in E. coli . Both a 1 μg ml −1 concentration of ciprofloxacin and a 65 mM concentration of DEA-NONOate achieved 99.9% inhibition of E. coli , verified using both optical density measurement of bacterial cultures in 96 well plates and a luminescent ATP activity assay. The bactericidal effects of DEA-NONOate against E. coli is proof-of-concept to pursue evaluation of nitric oxide-based formulations as antimicrobial and antiviral agents as hand sanitizers.
doi_str_mv 10.1038/s41429-020-00397-9
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7767638</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2473399315</sourcerecordid><originalsourceid>FETCH-LOGICAL-c498t-36ffeddc3279415207d764dea83c6606a967a9931a8ec824e21a18513bf57bbc3</originalsourceid><addsrcrecordid>eNp9kUtv1DAUhS0EotOBP8ACWWLDogE_Ej9YVKqq8pCqzgbWluPczLhK7MF2EPPvcZlSHgtWlny-e3yuD0IvKHlDCVdvc0tbphvCSEMI17LRj9CKKkUb2gr9GK0IYbRRipETdJrzbYUkl-opOuGcCyqlXqF4EYqfvUux93bC-xT3kIqHjOOIBw9ld5js7APgm83NxhY4wxYHX5J3OH73A-Ahhpjq7db6kAu-ym4HVd15i12c_LvK7_0UC85lGQ7P0JPRThme359r9OX91efLj8315sOny4vrxrValYaLcYRhcJxJ3dKOETlI0Q5gFXdCEGG1kFZrTq0Cp1gLjFqqOsr7sZN97_ganR9990s_w-AglGQns09-tulgovXmbyX4ndnGb0ZKIQVX1eD1vUGKXxfIxcw-O5gmGyAu2bBWcn6XoKvoq3_Q27ikUNczrCOC0q6rydaIHan61zknGB_CUGLu-jTHPk3t0_zs0-g69PLPNR5GfhVYAX4EcpXCFtLvt_9j-wNOBayh</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2506115551</pqid></control><display><type>article</type><title>Antimicrobial properties of diethylamine NONOate, a nitric oxide donor, against Escherichia coli: a pilot study</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Sysel, Annette M. ; Dunphy, Michael J. ; Bauer, Joseph A.</creator><creatorcontrib>Sysel, Annette M. ; Dunphy, Michael J. ; Bauer, Joseph A.</creatorcontrib><description>The emergence of SARS-CoV-2, the causative agent of COVID-19, highlights the increasing need for new and effective antiviral and antimicrobial agents. The FDA has recently banned several active ingredients used in hand sanitizers, including triclosan and benzethonium chloride. Nitric oxide (NO) is involved in the innate immune response and is a major component of macrophage-mediated attack on foreign viruses and bacteria. The specific aim of this study was to assess the antibacterial effects of 2-( N , N -diethylamino)-diazenolate-2-oxide (DEA-NONOate) against Escherichia coli ( E. coli ). A bacterial growth assay was compared to an adenosine triphosphate (ATP) activity assay at various time points to assess effects of DEA-NONOate on E. coli growth. A UV/Vis spectrophotometer was used to determine concentration of E. coli by measuring optical density (OD) at 630 nm. A luminescent assay was used to measure ATP activity correlating to viable cells. DEA-NONOate at a concentration of 65 mM was able to inhibit the growth of E. coli with the same efficacy as 1 μg ml −1 concentration of ciprofloxacin. Both the OD and ATP assays demonstrated a 99.9% reduction in E. coli . Both a 1 μg ml −1 concentration of ciprofloxacin and a 65 mM concentration of DEA-NONOate achieved 99.9% inhibition of E. coli , verified using both optical density measurement of bacterial cultures in 96 well plates and a luminescent ATP activity assay. The bactericidal effects of DEA-NONOate against E. coli is proof-of-concept to pursue evaluation of nitric oxide-based formulations as antimicrobial and antiviral agents as hand sanitizers.</description><identifier>ISSN: 0021-8820</identifier><identifier>EISSN: 1881-1469</identifier><identifier>DOI: 10.1038/s41429-020-00397-9</identifier><identifier>PMID: 33361779</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13/1 ; 13/106 ; 14/5 ; 631/326/2522 ; 692/420/254 ; Adenosine triphosphate ; Adenosine Triphosphate - metabolism ; Anti-Bacterial Agents - pharmacology ; Antimicrobial agents ; Antiviral agents ; ATP ; Bacteriology ; Biomedical and Life Sciences ; Bioorganic Chemistry ; Ciprofloxacin - pharmacology ; COVID-19 ; Density measurement ; E coli ; Escherichia coli - drug effects ; Hand Sanitizers - chemistry ; Humans ; Hydrazines - pharmacology ; Immune response ; Life Sciences ; Luminescent Measurements ; Medicinal Chemistry ; Microbiology ; Nitric oxide ; Organic Chemistry ; Pilot Projects ; Sanitizers ; Severe acute respiratory syndrome coronavirus 2 ; Spectrophotometry, Ultraviolet</subject><ispartof>Journal of antibiotics, 2021-04, Vol.74 (4), p.260-265</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited part of Springer Nature 2020</rights><rights>The Author(s), under exclusive licence to Springer Nature Limited part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c498t-36ffeddc3279415207d764dea83c6606a967a9931a8ec824e21a18513bf57bbc3</citedby><cites>FETCH-LOGICAL-c498t-36ffeddc3279415207d764dea83c6606a967a9931a8ec824e21a18513bf57bbc3</cites><orcidid>0000-0003-4972-6008</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33361779$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sysel, Annette M.</creatorcontrib><creatorcontrib>Dunphy, Michael J.</creatorcontrib><creatorcontrib>Bauer, Joseph A.</creatorcontrib><title>Antimicrobial properties of diethylamine NONOate, a nitric oxide donor, against Escherichia coli: a pilot study</title><title>Journal of antibiotics</title><addtitle>J Antibiot</addtitle><addtitle>J Antibiot (Tokyo)</addtitle><description>The emergence of SARS-CoV-2, the causative agent of COVID-19, highlights the increasing need for new and effective antiviral and antimicrobial agents. The FDA has recently banned several active ingredients used in hand sanitizers, including triclosan and benzethonium chloride. Nitric oxide (NO) is involved in the innate immune response and is a major component of macrophage-mediated attack on foreign viruses and bacteria. The specific aim of this study was to assess the antibacterial effects of 2-( N , N -diethylamino)-diazenolate-2-oxide (DEA-NONOate) against Escherichia coli ( E. coli ). A bacterial growth assay was compared to an adenosine triphosphate (ATP) activity assay at various time points to assess effects of DEA-NONOate on E. coli growth. A UV/Vis spectrophotometer was used to determine concentration of E. coli by measuring optical density (OD) at 630 nm. A luminescent assay was used to measure ATP activity correlating to viable cells. DEA-NONOate at a concentration of 65 mM was able to inhibit the growth of E. coli with the same efficacy as 1 μg ml −1 concentration of ciprofloxacin. Both the OD and ATP assays demonstrated a 99.9% reduction in E. coli . Both a 1 μg ml −1 concentration of ciprofloxacin and a 65 mM concentration of DEA-NONOate achieved 99.9% inhibition of E. coli , verified using both optical density measurement of bacterial cultures in 96 well plates and a luminescent ATP activity assay. The bactericidal effects of DEA-NONOate against E. coli is proof-of-concept to pursue evaluation of nitric oxide-based formulations as antimicrobial and antiviral agents as hand sanitizers.</description><subject>13/1</subject><subject>13/106</subject><subject>14/5</subject><subject>631/326/2522</subject><subject>692/420/254</subject><subject>Adenosine triphosphate</subject><subject>Adenosine Triphosphate - metabolism</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antimicrobial agents</subject><subject>Antiviral agents</subject><subject>ATP</subject><subject>Bacteriology</subject><subject>Biomedical and Life Sciences</subject><subject>Bioorganic Chemistry</subject><subject>Ciprofloxacin - pharmacology</subject><subject>COVID-19</subject><subject>Density measurement</subject><subject>E coli</subject><subject>Escherichia coli - drug effects</subject><subject>Hand Sanitizers - chemistry</subject><subject>Humans</subject><subject>Hydrazines - pharmacology</subject><subject>Immune response</subject><subject>Life Sciences</subject><subject>Luminescent Measurements</subject><subject>Medicinal Chemistry</subject><subject>Microbiology</subject><subject>Nitric oxide</subject><subject>Organic Chemistry</subject><subject>Pilot Projects</subject><subject>Sanitizers</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Spectrophotometry, Ultraviolet</subject><issn>0021-8820</issn><issn>1881-1469</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kUtv1DAUhS0EotOBP8ACWWLDogE_Ej9YVKqq8pCqzgbWluPczLhK7MF2EPPvcZlSHgtWlny-e3yuD0IvKHlDCVdvc0tbphvCSEMI17LRj9CKKkUb2gr9GK0IYbRRipETdJrzbYUkl-opOuGcCyqlXqF4EYqfvUux93bC-xT3kIqHjOOIBw9ld5js7APgm83NxhY4wxYHX5J3OH73A-Ahhpjq7db6kAu-ym4HVd15i12c_LvK7_0UC85lGQ7P0JPRThme359r9OX91efLj8315sOny4vrxrValYaLcYRhcJxJ3dKOETlI0Q5gFXdCEGG1kFZrTq0Cp1gLjFqqOsr7sZN97_ganR9990s_w-AglGQns09-tulgovXmbyX4ndnGb0ZKIQVX1eD1vUGKXxfIxcw-O5gmGyAu2bBWcn6XoKvoq3_Q27ikUNczrCOC0q6rydaIHan61zknGB_CUGLu-jTHPk3t0_zs0-g69PLPNR5GfhVYAX4EcpXCFtLvt_9j-wNOBayh</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Sysel, Annette M.</creator><creator>Dunphy, Michael J.</creator><creator>Bauer, Joseph A.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4972-6008</orcidid></search><sort><creationdate>20210401</creationdate><title>Antimicrobial properties of diethylamine NONOate, a nitric oxide donor, against Escherichia coli: a pilot study</title><author>Sysel, Annette M. ; Dunphy, Michael J. ; Bauer, Joseph A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c498t-36ffeddc3279415207d764dea83c6606a967a9931a8ec824e21a18513bf57bbc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>13/1</topic><topic>13/106</topic><topic>14/5</topic><topic>631/326/2522</topic><topic>692/420/254</topic><topic>Adenosine triphosphate</topic><topic>Adenosine Triphosphate - metabolism</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antimicrobial agents</topic><topic>Antiviral agents</topic><topic>ATP</topic><topic>Bacteriology</topic><topic>Biomedical and Life Sciences</topic><topic>Bioorganic Chemistry</topic><topic>Ciprofloxacin - pharmacology</topic><topic>COVID-19</topic><topic>Density measurement</topic><topic>E coli</topic><topic>Escherichia coli - drug effects</topic><topic>Hand Sanitizers - chemistry</topic><topic>Humans</topic><topic>Hydrazines - pharmacology</topic><topic>Immune response</topic><topic>Life Sciences</topic><topic>Luminescent Measurements</topic><topic>Medicinal Chemistry</topic><topic>Microbiology</topic><topic>Nitric oxide</topic><topic>Organic Chemistry</topic><topic>Pilot Projects</topic><topic>Sanitizers</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Spectrophotometry, Ultraviolet</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sysel, Annette M.</creatorcontrib><creatorcontrib>Dunphy, Michael J.</creatorcontrib><creatorcontrib>Bauer, Joseph A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of antibiotics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sysel, Annette M.</au><au>Dunphy, Michael J.</au><au>Bauer, Joseph A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antimicrobial properties of diethylamine NONOate, a nitric oxide donor, against Escherichia coli: a pilot study</atitle><jtitle>Journal of antibiotics</jtitle><stitle>J Antibiot</stitle><addtitle>J Antibiot (Tokyo)</addtitle><date>2021-04-01</date><risdate>2021</risdate><volume>74</volume><issue>4</issue><spage>260</spage><epage>265</epage><pages>260-265</pages><issn>0021-8820</issn><eissn>1881-1469</eissn><abstract>The emergence of SARS-CoV-2, the causative agent of COVID-19, highlights the increasing need for new and effective antiviral and antimicrobial agents. The FDA has recently banned several active ingredients used in hand sanitizers, including triclosan and benzethonium chloride. Nitric oxide (NO) is involved in the innate immune response and is a major component of macrophage-mediated attack on foreign viruses and bacteria. The specific aim of this study was to assess the antibacterial effects of 2-( N , N -diethylamino)-diazenolate-2-oxide (DEA-NONOate) against Escherichia coli ( E. coli ). A bacterial growth assay was compared to an adenosine triphosphate (ATP) activity assay at various time points to assess effects of DEA-NONOate on E. coli growth. A UV/Vis spectrophotometer was used to determine concentration of E. coli by measuring optical density (OD) at 630 nm. A luminescent assay was used to measure ATP activity correlating to viable cells. DEA-NONOate at a concentration of 65 mM was able to inhibit the growth of E. coli with the same efficacy as 1 μg ml −1 concentration of ciprofloxacin. Both the OD and ATP assays demonstrated a 99.9% reduction in E. coli . Both a 1 μg ml −1 concentration of ciprofloxacin and a 65 mM concentration of DEA-NONOate achieved 99.9% inhibition of E. coli , verified using both optical density measurement of bacterial cultures in 96 well plates and a luminescent ATP activity assay. The bactericidal effects of DEA-NONOate against E. coli is proof-of-concept to pursue evaluation of nitric oxide-based formulations as antimicrobial and antiviral agents as hand sanitizers.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>33361779</pmid><doi>10.1038/s41429-020-00397-9</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-4972-6008</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-8820
ispartof Journal of antibiotics, 2021-04, Vol.74 (4), p.260-265
issn 0021-8820
1881-1469
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7767638
source MEDLINE; Alma/SFX Local Collection
subjects 13/1
13/106
14/5
631/326/2522
692/420/254
Adenosine triphosphate
Adenosine Triphosphate - metabolism
Anti-Bacterial Agents - pharmacology
Antimicrobial agents
Antiviral agents
ATP
Bacteriology
Biomedical and Life Sciences
Bioorganic Chemistry
Ciprofloxacin - pharmacology
COVID-19
Density measurement
E coli
Escherichia coli - drug effects
Hand Sanitizers - chemistry
Humans
Hydrazines - pharmacology
Immune response
Life Sciences
Luminescent Measurements
Medicinal Chemistry
Microbiology
Nitric oxide
Organic Chemistry
Pilot Projects
Sanitizers
Severe acute respiratory syndrome coronavirus 2
Spectrophotometry, Ultraviolet
title Antimicrobial properties of diethylamine NONOate, a nitric oxide donor, against Escherichia coli: a pilot study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T03%3A03%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antimicrobial%20properties%20of%20diethylamine%20NONOate,%20a%20nitric%20oxide%20donor,%20against%20Escherichia%20coli:%20a%20pilot%20study&rft.jtitle=Journal%20of%20antibiotics&rft.au=Sysel,%20Annette%20M.&rft.date=2021-04-01&rft.volume=74&rft.issue=4&rft.spage=260&rft.epage=265&rft.pages=260-265&rft.issn=0021-8820&rft.eissn=1881-1469&rft_id=info:doi/10.1038/s41429-020-00397-9&rft_dat=%3Cproquest_pubme%3E2473399315%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2506115551&rft_id=info:pmid/33361779&rfr_iscdi=true